Kiniksa Pharmaceuticals International, plc (KNSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.06B |
| Enterprise Value | 2.9B |
| P/E Ratio | 69.48 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 6.74 |
| Price/Book Ratio | 8.82 |
| Enterprise/Revenue | 6.54 |
| Enterprise/EBITDA | 49.05 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
| Return On Assets | 0.09 |
| Return On Equity | 0.14 |
| Revenue | 677.56M |
| Revenue/Share | 10.84 |
| Gross Profit | 370.15M |
| EBITDA | 90.42M |
| Net Income | 59.01M |
| Diluted EPS | 0.75 |
| Total Cash | 525.93M |
| Total Cash/Share | 6.78 |
| Total Debt | 8.9M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.9 |
| Book Value Per Share | 8.43 |
| 52-Week Change | 125.61 |
| 52-Week High | 82.94 |
| 52-Week Low | 31.78 |
| Moving Average 50 Days | 58.8 |
| Moving Average 200 Days | 47.98 |
| Average Volume | 771,822 |
| Shares Outstanding | 76.21M |
| % Held by Institutions | 61.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |